Citation Impact
Citing Papers
Structural basis for RNA replication by the hepatitis C virus polymerase
2015 Science
Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
2016
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
2020
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
2017
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation
2014
Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation
2008
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Bowel Disorders
2016 Standout
Hepatocellular carcinoma
2016 Standout
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Hepatocellular carcinoma
2018 Standout
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Right lobe living donor liver transplantation: A review
2000
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Burden of liver diseases in the world
2018 Standout
Implantable Left Ventricular Assist Devices
1998
Device‐Associated Infections: A Macroproblem that Starts with Microadherence
2001 Standout
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
The MELD score in patients awaiting liver transplant: Strengths and weaknesses
2010
Hepatocellular carcinoma
2012 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Hepatocellular carcinoma
2021 Standout
Predicting the graft survival for heart–lung transplantation patients: An integrated data mining methodology
2009
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
2013
NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
2018
Irritable bowel syndrome
2016 Standout
Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease
2016
Validation of the HCC‐MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
2008
A more efficient method to generate integration-free human iPS cells
2011 StandoutNobel
Simultaneous Cadaver Pancreas Living-Donor Kidney Transplantation: A New Approach for the Type 1 Diabetic Uremic Patient
2000
Twelve Years' Experience with National Sharing of HLA-Matched Cadaveric Kidneys for Transplantation
2000
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
2020
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
2016
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
2012
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics
2016
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes
2021
Global burden of liver disease: 2023 update
2023 Standout
Management of HCC
2012
Comparison of Liver Transplant–Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States
2015
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Dietary Lipids and Functional Gastrointestinal Disorders
2013
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival
2021
Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant
1999 Standout
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
2020
Lung and heart-lung transplant practice patterns in pulmonary hypertension centers
2001
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list
2012
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
2017
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis
2016
Treatment of Infections Associated with Surgical Implants
2004 Standout
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
2014
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Waitlist Priority for Hepatocellular Carcinoma Beyond Milan Criteria: A Potentially Appropriate Decision Without a Structured Approach
2013
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Hepatocellular carcinoma
2022 Standout
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Irritable Bowel Syndrome
2015 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Hepatocellular Carcinoma
2019 Standout
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased‐Donor Liver Transplantation?
2018
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Alpha‐Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes
2018
Race and socioeconomic factors influencing early placement on the kidney transplant waiting list.
1998
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
2016
Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States
2017
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation
2014
Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma
2012
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Pro (With Caution): Extended oncologic indications in liver transplantation
2017
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18
2014
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States
2015
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
2015
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment
2014
MELDEQ : An alternative Model for End‐Stage Liver Disease score for patients with hepatocellular carcinoma
2015
Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy
2016
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listing
2015
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
2011
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Lower rates of receiving model for end‐stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma
2016
Tumor biology and pre‐transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
2013
Mechanisms of Renal Fibrosis
2017 Standout
Liver transplantation in Japan
2016
A long‐term experience with expansion of Milan criteria for liver transplant recipients
2018
Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study
2018
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening
2018
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy
2013
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Natural Flavonol, Myricetin, Enhances the Function and Survival of Cryopreserved Hepatocytes In Vitro and In Vivo
2019
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
2001 Standout
Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria
2014
Works of A.M. Harper being referenced
Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation
2006
OPTN/SRTR 2013 Annual Data Report: Intestine
2015
Perceived food and drug allergies in functional and organic gastrointestinal disorders
2002
Liver
2016
OPTN/SRTR 2011 Annual Data Report: Liver
2012
Waiting List Removal Rates Among Patients with Chronic and Malignant Liver Diseases
2006
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
2010
OPTN/SRTR 2016 Annual Data Report: Liver
2018
OPTN/SRTR 2013 Annual Data Report: Liver
2015
OPTN/SRTR 2012 Annual Data Report: Liver
2013
An Early Regional Experience with Expansion of Milan Criteria for Liver Transplant Recipients
2010
Excellent Liver Transplant Survival Rates Under the MELD/PELD System
2005
OPTN/SRTR 2015 Annual Data Report: Liver
2017
The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
1996
The UNOS OPTN waiting list and donor registry.
1997
An update on a successful simulation project: the UNOS Liver Allocation Model
2002